Results 181 to 190 of about 23,909 (233)

TRPA1 activation prompts lysosome-mediated Nrf2 degradation enhancing the killing of colorectal cancer cells. [PDF]

Redox Biol
Eskandari N, Delisi D, Vakili Saatloo M, Keceli G, Pinheiro N, Eblen S, Paolocci N, Gentile S.   +7 more
europepmc   +1 more source

Pharmacokinetics and Drug Interactions. [PDF]

Pharmaceutics
Choi MK, Song IS.
europepmc   +1 more source

Cannabidiol in pancreatic ductal adenocarcinoma: preclinical evidence, molecular mechanisms, and translational challenges. [PDF]

Cancer Cell Int
Esmaeli M, Dehghanpour Dehabadi M, Khaleghi AA.   +2 more
europepmc   +1 more source

The potential role of cannabidiol (CBD) in lung cancer therapy: a systematic review of preclinical and clinical evidence. [PDF]

Cancer Cell Int
Esmaeli M, Dehghanpour Dehabadi M.
europepmc   +1 more source

Real-world efficacy and safety of cannabidiol in developmental and epileptic encephalopathies. [PDF]

Epilepsia Open
Perulli M, Bianchetti M, Pantalone G, Quintiliani M, Gambardella ML, Picilli M, Marini C, Cesaroni E, Battaglia DI.   +8 more
europepmc   +1 more source

Prevalence and reasons for using cannabidiol, delta-8 tetrahydrocannabinol, cannabinol, cannabigerol, and hexahydrocannabinol among US adults. [PDF]

J Cannabis Res
Satybaldiyeva N, Yang KH, Kepner W, Ferran K, Leas EC.   +4 more
europepmc   +1 more source